TYK2 Presents an Attractive Target for the Treatme...
Autoimmune Diseases
New technologies in Multiple Sclerosis drug discovery
How HTRF and Alpha Technologies have contributed to MS drug discovery.
When AlphaLISA and HTRF meet inflammatory bowel di...
Inflammation of the digestive tract wall due to an overactivation of the...
Inflammation pathway reading, the way to tackle au...
An insight into published inflammatory signaling research.
Cytokines: an open gate to autoimmune disease ther...
Identification of cytokine-signaling inhibitors contributes a great deal...